162 papers
Immunology explores the intricate defense systems that keep our bodies safe from infections and disease. This field examines how our immune cells recognize threats, coordinate responses, and maintain a delicate balance between fighting invaders and avoiding self-harm. From understanding vaccine mechanisms to investigating autoimmune disorders, these studies reveal the dynamic biology protecting human health every day.
On Gist.Science, we ensure these critical discoveries remain accessible to everyone. We automatically process every new preprint in this category as it appears on bioRxiv, transforming complex research into both plain-language explanations and detailed technical summaries. This approach allows readers to grasp the core findings without getting lost in dense jargon, while still providing the depth needed for scientific inquiry.
Below are the latest immunology papers from bioRxiv, each accompanied by our curated summaries to help you navigate the newest breakthroughs in the field.
This study reveals that secondary immunization at the same site triggers a clonal burst-type expansion of existing germinal center B cells rather than recruiting local memory, a distinct response mechanism with significant implications for optimizing sequential vaccination strategies against evolving pathogens.
By analyzing single-cell RNA sequencing data from type 1 diabetes patients, this study identifies a resilient, dedifferentiated beta cell subpopulation enriched in survivors that evades immune destruction through an IRF1-driven transcriptional program characterized by upregulated immunomodulatory genes and downregulated autoantigens, offering potential new targets for disease prevention and reversal.
This study demonstrates that IFNγ stimulation induces human neurons to present a distinct, HLA-B-enriched repertoire of autoantigens via HLA class I molecules, which can be recognized by autoreactive CD8+ T cells to cause antigen-specific neuronal injury, thereby providing a platform for discovering and validating neuronal autoantigens in inflammatory CNS disorders.
This study demonstrates that southern African populations exhibit low pre-existing seroprevalence of neutralizing antibodies against gorilla adenovirus 32 (GRAd32), which remains unaffected by Ad26-based COVID-19 vaccination, thereby supporting its potential as an effective vector platform for future HIV vaccine trials in the region.
This study demonstrates that patients with GAD65 antibody-associated neurological disorders harbor pathogenic, HLA class I-restricted CD8+ T cells capable of recognizing specific GAD65 peptides and mediating cytotoxicity, highlighting a direct cellular mechanism of disease and identifying the 8.1 ancestral haplotype as a significant genetic risk factor.
This study demonstrates that combined PD-1/CTLA-4 checkpoint inhibition exacerbates post-myocardial infarction injury in mice by promoting CD8+ T cell-derived IFN-{gamma} production, which activates the JAK-STAT1 pathway in cardiac macrophages to drive a hyper-inflammatory response.
This study demonstrates that effective macrophage clearance of *Klebsiella pneumoniae* relies critically on inducible nitric oxide synthase (iNOS)-derived reactive nitrogen species rather than NADPH oxidase-generated reactive oxygen species, which are dispensable and undetectable during infection.
This study demonstrates that while human adenovirus serotype 4 (Ad4) exhibits limited replication in BALB/c mice, it still supports sufficient transgene expression to elicit protective immune responses against herpes simplex virus type 2, validating the mouse model for evaluating Ad4-based vaccine candidates.
The study demonstrates that the circadian clock regulates host susceptibility to enteric viral infections by driving rhythmic, pre-infection expression of the antiviral factor IRF1 in intestinal myeloid cells, thereby creating time-of-day-dependent variations in infection outcomes.
The study demonstrates that vaginally administered BEACON nanoparticles, composed of CpG oligodeoxynucleotides and CXCL9, significantly enhance protection against genital herpes by boosting local CD8+ tissue-resident memory T cells and mucosal antibody responses when used as an adjuvant with HSV-2 glycoproteins.